HRT Financial’s Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 HZON.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30,816
Closed -$14K 3650
2023
Q1
$14K Hold
30,816
﹤0.01% 2225
2022
Q4
$12K Buy
+30,816
New +$14.6K ﹤0.01% 2212

Other funds holding HZON.WS

HRT Financial's HZON.WS Position: Q2 2023 in Review

HRT Financial sold out of Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (HZON.WS) in Q2 2023, closing a stake of 30,816 shares — an estimated $14K sold.

HRT Financial first reported a position in HZON.WS in Q4 2022 and held it in 2 quarters. The position peaked at $14K in Q1 2023. 1 fund tracked by Wall St. Rank holds HZON.WS as of Q2 2023.

  • HRT Financial reported no remaining Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 30,816 Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $14K.
  • HRT Financial first reported a position in Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2022 and held it in 2 quarters.
  • HRT Financial's Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $14K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.